AdvantaPure will exhibit its high purity pharmaceutical and biopharmaceutical products at three industry trade shows this fall. AdvantaFlex(R) biopharm tubing and molded, Class VI silicone, single use systems will be the focus. Other items include silicone container closures and manifold identification solutions.
Veriteq, a Vaisala company, launches viewLinc 3.5 to aid life sciences companies seeking continuous monitoring systems specifically geared for larger enterprises.
Parallel Project Training introduces a project management training course designed to meet the specific needs for improved value for money in clinical research project
The high-purity products manufacturer expanded its operations in 2008 and recently did so again to meet the demand for its single use systems and molded components used in pharmaceutical and biopharmaceutical production. AdvantaPure converted existing space into cleanrooms for the manufacture of silicone manifolds and container closures.
A multidisciplinary team of researches specialized on Biotechnology, Biomedicine, Science and Environmental sciences, will research in new processes for the biosimilars production.
Curaxys is the new company specialized in the production of biosimilars medicines. It is an independent private company, located on the technological park of Cadiz Spain). The new venture is focuses in the development of new technological platforms.
Pharmalogical, Inc. has developed the little pink pill for the treatment and prevention of fibroadenoma: Fibrosolve. Fibrosolve has launched today, Nov. 16, 2009.
Compass Pharma Services, a pharmaceutical contract packager, recently completed a capital investment project to upgrade its contract pharmaceutical packaging capabilities to include “ISO Class 8” specifications for potent compounds.
Chris Singer, president of the International Section of the Pharmaceutical Research and Manufacturers of America, issued the following statement today on the U.S. Trade Representative’s (USTR) "Special 301" annual report to Congress, outlining the Administration’s global intellectual property agenda:
Yankee Public Relations is pleased to announce our inaugural life sciences symposium, designed to provide small and mid-sized biotechs with strategies for success in the present financial crisis. Biotech executives at public and private companies will share their experience, lessons learned and strategies for attracting investors.
Pharmaceutical companies are actively involved in the improvement of public health, all over the world, through their various access to medicine programs.
Compass Pharma Services, LLC improved customer service for pharmaceutical packaging, blister packaging, bottle filling and powder filling and other cGMP contract packaging services.NOT copy and paste the exact same top portion of your press release.
Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report which finds that the global market for the treatment of alcohol dependence will reach $304m by 2016.
Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which finds that the global insulin market is expected to witness double-digit growth during 2007-2012.
Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which anticipates that there will be a boom between 2010 and 2015 in the nanobiotechnology market.
Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which contains over 400 links to online copies of actual merger and acquisition contract documents as submitted to the Securities Exchange Commission by biopharma companies and their partners.
The report draws attention to how various high price vaccines have received different reception in the market. For instance, Wyeth’s Prevnar and Merck & Co’s Gardasil have experienced a rapid uptake driven by obvious medical need and public attention.
A new report would help companies prepare for new product launches as it specifically analyses new US White Papers on immunogenicity to bioloigcs and provides regulatory advice on working with the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA).
Authors of a new report say that the excipient chemical market is broken down into applications of organic, inorganic and United States Pharmacopeia (USP) water chemicals. Of these, organic chemicals have the largest share of the market and this segment is expected to be worth $3.7 billion by 2011, a CAGR of 3.8%.
Satisfied Users & 
Approved Press Releases
